Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1906 1
1913 1
1914 1
1934 1
1995 1
1998 1
1999 3
2000 3
2001 1
2002 2
2003 4
2005 1
2008 4
2009 4
2010 1
2011 2
2012 5
2013 4
2014 2
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
McInnes IB, Kavanaugh A, Gottlieb AB, Puig L, Rahman P, Ritchlin C, Brodmerkel C, Li S, Wang Y, Mendelsohn AM, Doyle MK; PSUMMIT 1 Study Group. McInnes IB, et al. Lancet. 2013 Aug 31;382(9894):780-9. doi: 10.1016/S0140-6736(13)60594-2. Epub 2013 Jun 13. Lancet. 2013. PMID: 23769296 Clinical Trial.
Hydroxychloroquine-induced inverse psoriasis.
Ullah A, Zeb H, Khakwani Z, Murphy FT. Ullah A, et al. Among authors: murphy ft. BMJ Case Rep. 2019 Feb 28;12(2):e224619. doi: 10.1136/bcr-2018-224619. BMJ Case Rep. 2019. PMID: 30824460 Free PMC article.
Watermelon stomach.
Murphy FT, Enzenauer RJ, Cheney CP. Murphy FT, et al. Arthritis Rheum. 1999 Mar;42(3):573. Arthritis Rheum. 1999. PMID: 10088782 No abstract available.
Etanercept-associated injection-site reactions.
Murphy FT, Enzenauer RJ, Battafarano DF, David-Bajar K. Murphy FT, et al. Arch Dermatol. 2000 Apr;136(4):556-7. doi: 10.1001/archderm.136.4.556. Arch Dermatol. 2000. PMID: 10768663 No abstract available.
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, Pak K, Kishi T, Flegel WA, Targoff IN, Miller FW, Lundberg IE, Rider LG, Mammen AL; Childhood Myositis Heterogeneity Collaborative Study Group. Sherman MA, et al. Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI226-SI234. doi: 10.1093/rheumatology/keac428. Rheumatology (Oxford). 2023. PMID: 35961028 Free PMC article.
Management of postmenopausal osteoporosis.
Murphy FT, Kivitz AJ, Sands EE. Murphy FT, et al. J Am Osteopath Assoc. 2003 Oct;103(10 Suppl 6):S6-11. J Am Osteopath Assoc. 2003. PMID: 14620079
PANCREATIC TRANSPLANTATIONS IN THE SPLEEN.
Pratt JH, Murphy FT. Pratt JH, et al. Among authors: murphy ft. J Exp Med. 1913 Mar 1;17(3):252-72. doi: 10.1084/jem.17.3.252. J Exp Med. 1913. PMID: 19867642 Free PMC article.
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials.
Gordon KB, Reich K, Crowley JJ, Korman NJ, Murphy FT, Poulin Y, Spelman L, Yamauchi PS, Mendelsohn AM, Parno J, Rozzo SJ, Ellis CN. Gordon KB, et al. Among authors: murphy ft. J Dermatolog Treat. 2022 Feb;33(1):219-228. doi: 10.1080/09546634.2020.1747590. Epub 2020 Apr 30. J Dermatolog Treat. 2022. PMID: 32349565 Clinical Trial.
46 results